INSIGHTS ON DRUG DEVELOPMENT
-
Manufacturing Challenges With High Concentration Biologics
Explore key process operations, some of the challenges in manufacturing high-concentration biologics, and factors to consider for process optimization.
-
Selecting The Right pDNA Supplier: 10 Key Factors To Consider
Selecting the right pDNA supplier is a critical decision that can significantly impact the success of your project or research. Consider these 10 key factors to help you make an informed choice.
-
Identify And Mitigate Absorption Risks With PBPK Modeling
Explore how PBPK models combined with custom and off-the shelf in vitro tools and solubility enhancement expertise can reduce the need for drug product reformulation or repeated preclinical or clinical studies.
-
Idea To Clinic: Accelerate Your Manufacturing Timeline To FIH Studies
Translating novel drug discoveries into clinical trials remains a complex endeavor. Learn how a CDMO with cutting-edge technologies can facilitate a smooth path from discovery to FIH studies.
-
Accelerating The Development And Production Of High-Quality Bispecific Antibodies3/7/2024
bsAbs are revolutionizing medicine by targeting two disease mechanisms simultaneously. Learn how an innovative platform offers excellent pairing and significantly enhances productivity and quality.
-
Breaking Bad Manufacturing Habits: Attaining Sustainable API Production3/6/2024
Sustainability is a growing issue in the pharmaceutical industry. Review strategies for reducing your carbon footprint and learn how the right CDMO can help drive the sustainable manufacture of APIs.
-
KinetiSol™ Technology3/6/2024
For poorly soluble drugs, overcoming absorption hurdles can hinder development. KinetiSol™ Technology empowers researchers to overcome solubility limitations and accelerate drug development.
-
Kinetisol Technology: Broader. Faster. Greener.3/5/2024
Explore how a solvent-free alternative for the production of amorphous solid dispersions (ASDs) not only improves manufacturability but also reduces the carbon footprint of ASD manufacturing.
DRUG DEVELOPMENT SOLUTIONS
-
Explore all of our gene therapy solutions for AAV and Lentivirus manufacturing based on 30+ years of experience to help bring your therapy to life.
-
We have defined work flows to assess and select solid forms in a cost and time efficient manner that meets the needs of each individual program.
-
As the number of poorly soluble compounds continues to increase in the industry development pipeline, conventional formulation strategies may not be sufficient to achieve acceptable levels of solubility in the gastrointestinal tract and hence absorption into the systemic circulation.
-
Your programs deserve the most comprehensive suite of CDMO services available, and Ajinomoto Bio-Pharma Services has the Power To Make your therapeutic vision a reality — from pre-clinical through commercial production.
-
Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.